v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenue $ 41,638 $ 9,350 $ 251,978 $ 13,350
Cost of revenue 120,000 4,321 121,696 6,648
Gross profit (78,362) 5,029 130,282 6,702
Operating Expenses        
Research and development 332,846 523,569 1,106,035 2,276,161
Selling, general and administrative 1,908,069 1,224,360 4,485,154 4,393,234
Total operating expenses 2,240,915 1,747,929 5,591,189 6,669,395
Operating loss (2,319,277) (1,742,900) (5,460,907) (6,662,693)
Other Income (Expense)        
Change in fair value of derivative liabilities 1,241,242 (2,237,050) 884,812 9,964,250
Gain on extinguishment of derivative liability 1,297,600 1,297,600
Interest income 206,726 176 242,047 18,333
Interest expense (143,131) (112,371) (443,961) (331,264)
Other (expense) (38,737) (592,592)
Total other income (expense) 2,563,700 (2,349,245) 1,387,906 9,651,319
Net income (loss) before provision for income taxes 244,423 (4,092,145) (4,073,001) 2,988,626
Provision for income taxes
Net Income (Loss) $ 244,423 $ (4,092,145) $ (4,073,001) $ 2,988,626
Weighted average number of shares of common stock outstanding, basic 10,239,568 3,076,486 8,803,055 3,027,298
Basic net income (loss) per share of common stock $ 0.02 $ (1.33) $ (0.46) $ 0.99
Weighted average number of shares of common stock outstanding, diluted 10,421,502 3,076,486 8,803,055 3,847,742
Diluted net loss per share of common stock $ (0.05) $ (1.33) $ (0.46) $ (1.12)